Evidence map›Paper›PMID 32764797›Full record

ArticlePloS one2020

Maternal administration of probiotics promotes gut development in mouse offsprings.

Yueyue Yu, Jing Lu, Kaitlyn Oliphant, Nikhilesh Gupta, Katerina Claud, Lei Lu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Characteristics ofHeliyon · 2024
    Article
  9. Article
  10. Nutrients · 2024
    Article
  11. Frontiers in nutrition · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Frontiers in microbiology · 2022
    Article
  17. Review
  18. Probiotics in the Prevention and Treatment of Necrotizing Enterocolitis.Pediatric gastroenterology, hepatology & nutrition · 2021
    Review
  19. Dynamics of the preterm gut microbiome in health and disease.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Review
  20. Oxidative medicine and cellular longevity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yueyue YuDepartment of Pediatrics, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Jing LuDepartment of Pediatrics, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Kaitlyn OliphantDepartment of Pediatrics, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Nikhilesh GuptaDepartment of Pediatrics, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Katerina ClaudDepartment of Pediatrics, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Lei LuDepartment of Pediatrics, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-9253-9753
University of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing enterocolitis is the most common gastrointestinal disorder in premature neonates. This disease is characterized by massive epithelial necrosis, gut barrier dysfunction and improper mucosal defense development. Studies have shown that probiotic administration can decrease NEC incidence and mortality. The proposed mechanisms of probiotics for the prevention of NEC are: promotion of intestinal development; improved barrier function through decreased apoptosis and improved mucin production; decreased expression of proinflammatory cytokines IL6, IL8, and TNFα, and modulation of microbiota dysbiosis in preterm infants. However, reported sepsis in the immunocompromised preterm host has deterred routine prophylactic administration of probiotics in the neonatal intensive care unit. We hypothesize that maternal administration of probiotics to pregnant mouse dams can recapitulate the beneficial effects observed in neonates fed with probiotics directly. We exposed pregnant mice to the probiotics and monitored the changes in the developing intestines of the offspring. Pregnant mice were fed daily with the probiotics Lactobacillus acidophilus and Bifidobacterium infantis (LB) from embryonic day15 to 2-week-old postnatally. Intraperitoneal administration of IL-1β in the pups was used to model proinflammatory insults. Sera were collected at 2 weeks of age and evaluated for inflammatory cytokines by enzyme-linked-immunosorbent-assay and gut permeability by Fluorescein isothiocyanate-dextran tracer assay. Ileal tissues were collected for the evaluation of apoptosis and proliferation of the intestinal epithelium; as well as mucin and tight junction integrity at mucosal surface by immunofluorescent staining. We find that maternal LB exposure facilitated intestinal epithelial cell differentiation, prevented loss of mucin and preserved the intestinal integrity and barrier function and decreased serum levels of IL-1β, TNF-α and IL-6 in the preweaned offsprings. in LB exposed pups. We demonstrate that maternal probiotic supplementation promotes gut maturation in developing offspring. This is potentially a safe alternative therapy to induce intestinal maturation and prevent prematurity-associated neonatal disorders.

Indexed as

Maternal ExposureAnimalsAnimals, NewbornBifidobacterium longum subspecies infantisCell DifferentiationDisease Models, AnimalEnterocolitis, NecrotizingFecesFemaleGastrointestinal MicrobiomeHost Microbial InteractionsHumansInfant, NewbornInfant, PrematureInterleukin-1betaIntestinal MucosaInterleukin-1beta

Identifiers

PMID32764797
PMCPMC7413491
OpenAlexW3047920680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.